POSC57 The Costs and Time Associated with the Infusions of PD-1 Inhibitors in Melanoma Patients in Sweden
Jan 1, 2022, 00:00 AM
10.1016/j.jval.2021.11.462
https://www.valueinhealthjournal.com/article/S1098-3015(21)02257-9/fulltext
Section Title :
Section Order :
11235
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02257-9&doi=10.1016/j.jval.2021.11.462